0

PAC-1

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP315183212
CAS315183-21-2
Structure
MDL NumberMFCD03302441
Molecular Weight392.49
InChI KeyYQNRVGJCPCNMKT-LFVJCYFKSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥10 mg/mL; deionized water: ≤2 mg/mL
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size5MG, 25MG
Storage Conditionsroom temp
1

Derivatives of Procaspase-Activating Compound 1 (PAC-1) and Their Anticancer Activities

Howard S Roth, Paul J Hergenrother

Curr Med Chem. 2016;23(3):201-41.

PMID: 26630918

1

PAC-1 and Its Derivative WF-210 Inhibit Angiogenesis by Inhibiting VEGF/VEGFR Pathway

Fangyang Wang, Lihui Wang, Yi Li, Nannan Wang, Yating Wang, Qi Cao, Ping Gong, Jingyu Yang, Chunfu Wu

Eur J Pharmacol. 2018 Feb 15;821:29-38.

PMID: 29269017

1

PACAP stimulates insulin secretion by PAC 1 receptor and ion channels in β-cells

Mengmeng Liu, Xiaohua Yang, Tao Bai, Zhihong Liu, Tao Liu, Yan Wang, Lijuan Cui, Yunfeng Liu, Yi Zhang

Cell Signal. 2019 Sep;61:48-56.

PMID: 31085235

1

PACAP38 and PAC 1 receptor blockade: a new target for headache?

Eloisa Rubio-Beltrán, Edvige Correnti, Marie Deen, Katharina Kamm, Tim Kelderman, Laura Papetti, Simone Vigneri, Antoinette MaassenVanDenBrink, Lars Edvinsson, European Headache Federation School of Advanced Studies (EHF-SAS)

J Headache Pain. 2018 Aug 7;19(1):64.

PMID: 30088106

1

SM-1, a Novel PAC-1 Derivative, Activates procaspase-3 and Causes Cancer Cell Apoptosis

Yanfen Chen, Meng Sun, Jingsong Ding, Qubo Zhu

Cancer Chemother Pharmacol. 2016 Sep;78(3):643-54.

PMID: 27488460

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode